Gemcitabine, paclitaxel, and doxorubicin as first-line therapy for patients with advanced urothelial carcinoma and renal insufficiency: A phase II study.

Authors

Lance C. Pagliaro

The University of Texas MD Anderson Cancer Center, Houston, TX

Lance C. Pagliaro , Mark F. Munsell , Deborah Harris , Robert L. Carolla , Arlene O. Siefker-Radtke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT00478361

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4528)

DOI

10.1200/jco.2013.31.15_suppl.4528

Abstract #

4528

Poster Bd #

Abstract Disclosures

FEATURED